Teleflex Incorporated (NYSE:TFX – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $119.99 and traded as high as $136.32. Teleflex shares last traded at $134.1630, with a volume of 531,427 shares traded.
Analysts Set New Price Targets
TFX has been the topic of a number of research reports. Royal Bank Of Canada upgraded shares of Teleflex from a “sector perform” rating to an “outperform” rating and upped their target price for the company from $135.00 to $155.00 in a research report on Friday, May 8th. Weiss Ratings reiterated a “sell (d)” rating on shares of Teleflex in a research report on Wednesday, June 24th. Wall Street Zen raised shares of Teleflex from a “sell” rating to a “hold” rating in a research note on Saturday, June 27th. BMO Capital Markets started coverage on shares of Teleflex in a report on Wednesday. They issued an “outperform” rating and a $159.00 price objective on the stock. Finally, Wells Fargo & Company raised their price objective on shares of Teleflex from $130.00 to $138.00 and gave the company an “equal weight” rating in a research note on Friday, May 8th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $147.44.
Read Our Latest Analysis on TFX
Teleflex Stock Performance
Teleflex (NYSE:TFX – Get Free Report) last posted its earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, topping the consensus estimate of $1.21 by $0.18. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The firm had revenue of $548.30 million for the quarter, compared to analyst estimates of $536.91 million. During the same period in the previous year, the company posted $1.44 earnings per share. The company’s revenue for the quarter was up 32.3% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, research analysts predict that Teleflex Incorporated will post 6.7 earnings per share for the current year.
Teleflex Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th were issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. The ex-dividend date was Friday, May 22nd. Teleflex’s payout ratio is -5.96%.
Institutional Trading of Teleflex
A number of large investors have recently bought and sold shares of TFX. Hsbc Holdings PLC lifted its stake in Teleflex by 4.7% in the first quarter. Hsbc Holdings PLC now owns 1,861 shares of the medical technology company’s stock valued at $222,000 after buying an additional 84 shares in the last quarter. Banque Cantonale Vaudoise boosted its holdings in shares of Teleflex by 82.5% in the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after buying an additional 113 shares during the period. Hantz Financial Services Inc. boosted its holdings in shares of Teleflex by 40.5% in the fourth quarter. Hantz Financial Services Inc. now owns 392 shares of the medical technology company’s stock valued at $48,000 after buying an additional 113 shares during the period. UMB Bank n.a. increased its position in shares of Teleflex by 57.1% during the fourth quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after acquiring an additional 113 shares in the last quarter. Finally, Maryland State Retirement & Pension System increased its position in shares of Teleflex by 1.5% during the fourth quarter. Maryland State Retirement & Pension System now owns 8,652 shares of the medical technology company’s stock worth $1,056,000 after acquiring an additional 129 shares in the last quarter. 95.62% of the stock is owned by institutional investors.
Teleflex Company Profile
Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.
The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.
Featured Articles
- Five stocks we like better than Teleflex
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
